UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial

Human vaccines & immunotherapeutics, 2020-02, Vol.16 (2), p.452-459

2020

Volltextzugriff (PDF)

Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G

Southern medical journal (Birmingham, Ala.), 2010-09, Vol.103 (9), p.856-863

2010

Volltextzugriff (PDF)

Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P)

Blood coagulation & fibrinolysis, 2009-10, Vol.20 (7), p.535-540

2009

Volltextzugriff (PDF)

Progress in the treatment of bleeding disorders

Thrombosis research, 2011-01, Vol.127, p.S3-S5

Bergman, Garrett E

2011

Volltextzugriff (PDF)

Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records

Thrombosis and haemostasis, 2012-04, Vol.107 (4), p.662-672

2012

Volltextzugriff (PDF)

The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database

Clinical transplantation, 2011-07, Vol.25 (4), p.E455-E462

2011

Volltextzugriff (PDF)

Large Cohort of Symptomatic Female Carriers of Hemophilia in an Extended Native American Family

Blood, 2015-12, Vol.126 (23), p.4700-4700

2015

Volltextzugriff (PDF)

Progress in the treatment of bleeding disorders: Challenges and innovations in the treatment of bleeding disorders

Thrombosis research, 2011, Vol.127

BERGMAN, Garrett E

2011

Volltextzugriff (PDF)

A US Pilot Data Registry for Patients with Congenital Thrombotic Thombocytopenic Purpura (CTTP): The Unexpected Results

Blood, 2014-12, Vol.124 (21), p.5036-5036

2014

Volltextzugriff (PDF)

The Evaluation of a Prothrombotic Risk in a Human Fibrinogen Concentrate

Blood, 2008-11, Vol.112 (11), p.4064-4064

2008

Volltextzugriff (PDF)

Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B

Thrombosis and haemostasis, 1996-01, Vol.75 (1), p.30-35

1996

Volltextzugriff (PDF)

Comparative Immunogenicity of Two Forms of Porcine Factor VIII in Cynomolgus Monkeys

Blood, 2004-11, Vol.104 (11), p.3079-3079

2004

Volltextzugriff (PDF)

Pre-Surgical PK Analyses in VWD Patients Undergoing Surgery Do Not Reliably Guide Dosing Due to Intra-Individual Variability in in-Vivo Recovery of VWF:RCo

Blood, 2008-11, Vol.112 (11), p.1217-1217

2008

Volltextzugriff (PDF)

Purified Factor IX Using Monoclonal Immunoaffinity Technique: Clinical Trials in Hemophilia B and Comparison to Prothrombin Complex Concentrates

Blood, 1992-02, Vol.79 (3), p.568-575

1992

Volltextzugriff (PDF)

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status

The Lancet (British edition), 1993-09, Vol.342 (8873), p.700-703

1993

Volltextzugriff (PDF)

Variability of In Vivo Recovery of Factor IX after Infusion of Monoclonal Antibody Purified Factor IX Concentrates in Patients with Hemophilia B

Thrombosis and haemostasis, 1995, Vol.73 (5), p.779-784

1995

Volltextzugriff (PDF)

Emergency management of pediatric trauma

The Journal of pediatrics, 1986, Vol.108 (1), p.144-144

Bergman, Garrett E.

1986

Volltextzugriff (PDF)

292 pages, $27.95 Robert F. Weir Selective nontreatment of handicapped newborns 1984 Oxford University Press New York

The Journal of pediatrics, 1985, Vol.106 (2), p.304-304

Bergman, Garrett E.

1985

Volltextzugriff (PDF)

Tomas Silber Ethical issues in the treatment of children and adolescents 1983 Slack Incorporated Thorofare, N.J

The Journal of pediatrics, 1984, Vol.105 (3), p.499-500

Bergman, Garrett E.

1984

Volltextzugriff (PDF)

Cancer in the young

The Journal of pediatrics, 1983-08, Vol.103 (2), p.333-333

Bergman, Garrett E.

1983

Volltextzugriff (PDF)

Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate

The Lancet (British edition), 1995-11, Vol.346 (8985), p.1296-1298

1995

Volltextzugriff (PDF)

Factor VIII inhibitors

The Lancet (British edition), 1993-10, Vol.342 (8879), p.1109-1110

1993

Volltextzugriff (PDF)

Concomitant Treatment with Factor IX Concentrates and Antif ibrinolytics in Hemophilia B

Acta haematologica, 1995, Vol.94 (1), p.43-48

1995

Volltextzugriff (PDF)

Safety of high doses of a monoclonal antibody‐purified factor IX concentrate

American journal of hematology, 1995-05, Vol.49 (1), p.92-94

1995

Volltextzugriff (PDF)

Safety of immune globulin preparations with regard to human immunodeficiency virus

The Journal of infectious diseases, 1990-10, Vol.162 (4), p.997-997

1990

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(42)
Newsletter-Artikel
(1)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial

Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G

Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P)

Progress in the treatment of bleeding disorders

Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records

The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database

Large Cohort of Symptomatic Female Carriers of Hemophilia in an Extended Native American Family

Progress in the treatment of bleeding disorders: Challenges and innovations in the treatment of bleeding disorders

A US Pilot Data Registry for Patients with Congenital Thrombotic Thombocytopenic Purpura (CTTP): The Unexpected Results

The Evaluation of a Prothrombotic Risk in a Human Fibrinogen Concentrate

Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B

Comparative Immunogenicity of Two Forms of Porcine Factor VIII in Cynomolgus Monkeys

Pre-Surgical PK Analyses in VWD Patients Undergoing Surgery Do Not Reliably Guide Dosing Due to Intra-Individual Variability in in-Vivo Recovery of VWF:RCo

Purified Factor IX Using Monoclonal Immunoaffinity Technique: Clinical Trials in Hemophilia B and Comparison to Prothrombin Complex Concentrates

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status

Variability of In Vivo Recovery of Factor IX after Infusion of Monoclonal Antibody Purified Factor IX Concentrates in Patients with Hemophilia B

Emergency management of pediatric trauma

292 pages, $27.95 Robert F. Weir Selective nontreatment of handicapped newborns 1984 Oxford University Press New York

Tomas Silber Ethical issues in the treatment of children and adolescents 1983 Slack Incorporated Thorofare, N.J

Cancer in the young

Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate

Factor VIII inhibitors

Concomitant Treatment with Factor IX Concentrates and Antif ibrinolytics in Hemophilia B

Safety of high doses of a monoclonal antibody‐purified factor IX concentrate

Safety of immune globulin preparations with regard to human immunodeficiency virus

Suchergebnisse filtern